Klaria Pharma Holding AB (KLAR) - Total Liabilities

Latest as of March 2026: Skr50.62 Million SEK ≈ $5.45 Million USD

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has total liabilities worth Skr50.62 Million SEK (≈ $5.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Klaria Pharma Holding AB (KLAR) net asset momentum to track the company's year-over-year net asset growth rate.

Klaria Pharma Holding AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Klaria Pharma Holding AB's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Klaria Pharma Holding AB to measure how efficiently the company converts operating cash flow to free cash.

Klaria Pharma Holding AB Competitors by Total Liabilities

The table below lists competitors of Klaria Pharma Holding AB ranked by their total liabilities.

Company	Country	Total Liabilities
Compugates Holdings Bhd KLSE:5037	Malaysia	RM73.01 Million
Sungwoo Electronics Co. Ltd KQ:081580	Korea	₩47.34 Billion
Barinthus Biotherapeutics plc NASDAQ:BRNS	USA	$24.64 Million
aXichem AB ST:AXIC-A	Sweden	Skr9.69 Million
Maniker KO:027740	Korea	₩116.88 Billion
Scandinavian Enviro Systems AB ST:SES	Sweden	Skr55.26 Million
Allied Gaming & Entertainment Inc. NASDAQ:AGAE	USA	$35.21 Billion
JV SPAC Acquisition Corp. Class A Ordinary Share NASDAQ:JVSA	USA	$2.33 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Klaria Pharma Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Klaria Pharma Holding AB stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.06	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Klaria Pharma Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Klaria Pharma Holding AB (2014–2025)

The table below shows the annual total liabilities of Klaria Pharma Holding AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr44.65 Million ≈ $4.80 Million	-17.26%
2024-12-31	Skr53.96 Million ≈ $5.81 Million	+69.62%
2023-12-31	Skr31.81 Million ≈ $3.42 Million	-28.01%
2022-12-31	Skr44.19 Million ≈ $4.76 Million	-9.62%
2021-12-31	Skr48.89 Million ≈ $5.26 Million	+114.33%
2020-12-31	Skr22.81 Million ≈ $2.45 Million	+16.29%
2019-12-31	Skr19.62 Million ≈ $2.11 Million	+69.77%
2018-12-31	Skr11.55 Million ≈ $1.24 Million	+391.91%
2017-12-31	Skr2.35 Million ≈ $252.79K	+17.80%
2016-12-31	Skr1.99 Million ≈ $214.59K	-13.04%
2015-12-31	Skr2.29 Million ≈ $246.76K	+356.14%
2014-12-31	Skr502.69K ≈ $54.10K	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$22.77 Million

Skr211.54 Million SEK

Market Cap Rank

#24639 Global

#493 in Sweden

Share Price

Skr0.86

Change (1 day)

+5.26%

52-Week Range

Skr0.45 - Skr1.22

All Time High

Skr17.00